Secondly, you talked in your presentation about the international connections and communications that you have. It seems that some countries seem to be able to act more quickly in terms of pulling products, and we may have a product on here that—it was mentioned—takes two years to assess, and you talked about having a priority.
I'm just wondering, do you communicate with them on the approval process, the effects, and then the withdrawal of a product? Say in the United States there's a significant pharmaceutical product that has been withdrawn from the market. There's not much difference between a person living in Ontario and in Michigan, so does it automatically come back, and do we pull that product?